PATRONO, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 2.202
EU - Europa 1.771
AS - Asia 1.503
SA - Sud America 107
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 5.597
Nazione #
US - Stati Uniti d'America 2.178
SG - Singapore 542
CN - Cina 500
UA - Ucraina 367
IE - Irlanda 312
TR - Turchia 298
SE - Svezia 253
GB - Regno Unito 214
DE - Germania 173
FR - Francia 163
IT - Italia 105
IN - India 99
BR - Brasile 94
FI - Finlandia 91
RU - Federazione Russa 60
HK - Hong Kong 16
CA - Canada 13
AR - Argentina 7
BE - Belgio 7
IQ - Iraq 7
MX - Messico 6
PL - Polonia 6
VN - Vietnam 6
EU - Europa 5
IL - Israele 5
NL - Olanda 5
SA - Arabia Saudita 5
BD - Bangladesh 4
CZ - Repubblica Ceca 4
IR - Iran 4
AT - Austria 3
EG - Egitto 3
TW - Taiwan 3
UY - Uruguay 3
AU - Australia 2
ES - Italia 2
HN - Honduras 2
JP - Giappone 2
KG - Kirghizistan 2
QA - Qatar 2
BB - Barbados 1
BN - Brunei Darussalam 1
CG - Congo 1
CL - Cile 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
ID - Indonesia 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PK - Pakistan 1
RO - Romania 1
RS - Serbia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 5.597
Città #
Singapore 444
Jacksonville 411
Chandler 365
Dublin 310
Southend 172
Izmir 147
Princeton 143
Beijing 116
Wilmington 105
Nanjing 102
Santa Clara 79
Ashburn 75
Dearborn 75
Cambridge 67
Munich 44
The Dalles 42
Ann Arbor 41
Tongling 39
Nanchang 36
Woodbridge 35
Altamura 29
Shenyang 23
Kunming 21
Los Angeles 20
New York 20
Helsinki 19
Boardman 18
Jiaxing 18
Grevenbroich 17
Hebei 17
Hong Kong 16
Changsha 15
Washington 15
Augusta 13
Hefei 13
Norwalk 13
Chieti 12
Houston 12
Moscow 12
Tianjin 12
Council Bluffs 11
San Mateo 10
Falls Church 9
Hangzhou 9
Orange 8
Brussels 7
Chicago 7
Jinan 7
Lanzhou 7
Leawood 7
Seattle 7
Brooklyn 6
Shanghai 6
Boston 5
Frankfurt am Main 5
San Francisco 5
São Paulo 5
Turku 5
Zhengzhou 5
Brno 4
Hackney 4
Padua 4
Queens 4
Taiyuan 4
Tavagnacco 4
Toronto 4
Belo Horizonte 3
Campinas 3
Charlotte 3
Erbil 3
Guangzhou 3
Kocaeli 3
Montevideo 3
Montreal 3
Mountain View 3
Pescara 3
Pune 3
Roubaix 3
San Jose 3
Santos 3
Secaucus 3
Taipei 3
Tappahannock 3
Warsaw 3
Baghdad 2
Bexley 2
Bishkek 2
Bologna 2
Buffalo 2
Cairo 2
Catania 2
Changchun 2
Chaoyang 2
Clarksburg 2
Denver 2
Detroit 2
Doha 2
Goiânia 2
Guarulhos 2
Haikou 2
Totale 3.428
Nome #
Low-dose aspirin acetylates cyclooxygenase-1 in human colorectal mucosa: implications for the chemoprevention of colorectal cancer. 136
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 125
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 123
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 115
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 112
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 112
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 109
Platelet-specific deletion of cyclooxygenase-1 ameliorates dextran sulfate sodium-induced colitis in mice. 109
Thromboxane biosynthesis and pulmonary function in cystic fibrosis 108
Insulin resistance as a determinant of platelet activation in obese women. 98
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 98
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 98
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 95
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 94
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 92
Aspirin, platelet inhibition and cancer prevention. 91
Cyclooxygenase-2 expression and inhibition in atherothrombosis. 90
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 90
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 89
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 89
Determinants of platelet activation in Alzheimer's disease 89
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 88
Cyclooxygenase-2 polymorphism: putting a brake on the inflammatory response to vascular injury? 87
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 86
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 86
Role of Platelet Activation in Dementia 85
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 83
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 83
Increased thromboxane biosynthesis in essential thrombocythemia 82
Effects of nabumetone on prostanoid biosynthesis in humans. 82
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. 81
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 81
Aspirin after acute myocardial infarction: a systematic approach to compare the hemostatic effects of three different doses. 80
Mechanisms, consequences, and prevention of coronary graft failure 80
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 79
Determinants of platelet activation in human essential hypertension. 79
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 78
Nutraceuticals in diabetes and metabolic syndrome. 77
Soluble CD40L as an indicator of platelet Activation in Heart Failure 77
Determinants of Platelet Activation in Heart Failure. 75
Insulin resistance as a determinant of platelet activation in obese women 75
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 75
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 74
Platelet activation in obese women: role of inflammation and oxidant stress. 73
Drugs, prostaglandins, and renal function. 73
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 73
Antiplatelet agents in the prevention of diabetic vascular complications 73
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 71
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 71
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 71
Determinants of Platelet Activation in Heart Failure. 70
Cyclooxygenase-2 expression and inhibition in human monocytes 70
Short term Vitamin E treatment normalizes LDL oxidative susceptibility in diabetic subjects. 69
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 69
Insulin resistance as a determinant of platelet activation in obese women 68
Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothiophenyl)-1-indanone (L-745,337), on the cyclo-oxygenase activity of human blood prosta-glandin endoperoxide synthases 67
In vivo formation of 8-isoprostaglandin F-2 alpha and platelet activation in diabetes mellitus. Effects of improved metabolic control and vitamin E supplementation 67
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 67
Effects of successful weight loss or pioglitazone on thromboxane-dependent platelet activation in obese women 66
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 64
Thromboxane biosynthesis in cardiovascular diseases 63
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 63
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors 62
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 61
In vivo formation of 8-EPI-prostaglandin F2 alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 58
Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: A mechanistic and clinical perspective 58
Increased thromboxane biosynthesis in type IIa hypercholesterolemia 55
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 54
Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man 53
In vivo platelet activation in diabetes mellitus 41
null 39
Off-pump coronary artery bypass grafting: 30 years of debate 27
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial 1
Totale 5.752
Categoria #
all - tutte 24.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.190


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021386 0 1 72 1 26 100 3 4 79 70 10 20
2021/2022275 1 4 6 47 26 5 7 18 25 9 41 86
2022/2023989 81 129 80 98 89 211 57 62 125 13 19 25
2023/2024417 32 10 31 13 30 113 126 18 2 3 5 34
2024/20251.184 95 283 202 16 9 41 12 29 79 41 128 249
2025/2026288 237 51 0 0 0 0 0 0 0 0 0 0
Totale 5.752